EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.2.2.8 | Acanthamoeba Keratitis |
32997695 |
Production of a polyclonal antibody against inosine-uridine preferring nucleoside hydrolase of Acanthamoeba castellanii and its access to diagnosis of Acanthamoeba keratitis. |
therapeutic application
unassigned |
1
0 |
| 3.2.2.8 | Anthrax |
21142217 |
Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis. |
therapeutic application
unassigned |
3
0 |
| 3.2.2.8 | Anthrax |
21318235 |
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 3.2.2.8 | Anthrax |
28300596 |
Combined virtual screening, MMPBSA, molecular docking and dynamics studies against deadly anthrax: An in silico effort to inhibit Bacillus anthracis nucleoside hydrolase. |
therapeutic application
unassigned |
1
0 |
| 3.2.2.8 | Bacterial Infections |
21318235 |
Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 3.2.2.8 | Infections |
17644455 |
Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections. |
therapeutic application
unassigned |
2
0 |
| 3.2.2.8 | Infections |
24966857 |
Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection. |
ongoing research
therapeutic application
unassigned |
3
2
0 |
| 3.2.2.8 | Infections |
28280494 |
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection. |
therapeutic application
unassigned |
1
0 |
| 3.2.2.8 | Infections |
29808562 |
Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.2.2.8 | Infections |
31024556 |
The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice. |
therapeutic application
unassigned |
1
0 |
